Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Cook

Showing results (1631-1640 of 1,674) with videos related to

Pageof 168
Sort By:
The Lancet. Oncology|December 28, 2020
Objective responses to first-line neoadjuvant carboplatin-paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trialRobert D Morgan, Iain A McNeish, Adrian D Cook, et al.
The Lancet. Oncology|June 28, 2015
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trialAmit M Oza, Adrian D Cook, Jacobus Pfisterer, et al.
Journal of Economic Entomology|October 16, 2015
Lepidoptera (Crambidae, Noctuidae, and Pyralidae) Injury to Corn Containing Single and Pyramided Bt Traits, and Blended or Block Refuge, in the Southern United StatesD D Reisig, D S Akin, J N All, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 18, 2018
A Randomized Multicenter Phase II Study of Docosahexaenoic Acid in Patients with a History of Breast Cancer, Premalignant Lesions, or Benign Breast DiseaseAyca Gucalp, Xi K Zhou, Elise D Cook, et al.
G3 (Bethesda, Md.)|December 20, 2015
The Mouse Universal Genotyping Array: From Substrains to SubspeciesAndrew P Morgan, Chen-Ping Fu, Chia-Yu Kao, et al.
European Urology|June 26, 2025
Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate DataSarah Burdett, David J Fisher, Jayne F Tierney, et al.
Histopathology|July 22, 2014
Immunohistochemical application of a highly sensitive and specific murine monoclonal antibody recognising the extracellular domain of the human hepatocyte growth factor receptor (MET)Aaron M Gruver, Ling Liu, Peter Vaillancourt, et al.
Journal of Bacteriology|September 29, 2011
Genome sequences for five strains of the emerging pathogen Haemophilus haemolyticusI King Jordan, Andrew B Conley, Ivan V Antonov, et al.
Lancet (London, England)|December 4, 2019
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trialAndrew R Clamp, Elizabeth C James, Iain A McNeish, et al.
Journal of the National Cancer Institute|January 20, 2005
Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Scott M Lippman, Phyllis J Goodman, Eric A Klein, et al.
Pageof 168

Showing results (1631-1640 of 1,674) with videos related to

Sort By:
Pageof 168
The Lancet. Oncology|December 28, 2020
Objective responses to first-line neoadjuvant carboplatin-paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trialRobert D Morgan, Iain A McNeish, Adrian D Cook, et al.
The Lancet. Oncology|June 28, 2015
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trialAmit M Oza, Adrian D Cook, Jacobus Pfisterer, et al.
Journal of Economic Entomology|October 16, 2015
Lepidoptera (Crambidae, Noctuidae, and Pyralidae) Injury to Corn Containing Single and Pyramided Bt Traits, and Blended or Block Refuge, in the Southern United StatesD D Reisig, D S Akin, J N All, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 18, 2018
A Randomized Multicenter Phase II Study of Docosahexaenoic Acid in Patients with a History of Breast Cancer, Premalignant Lesions, or Benign Breast DiseaseAyca Gucalp, Xi K Zhou, Elise D Cook, et al.
G3 (Bethesda, Md.)|December 20, 2015
The Mouse Universal Genotyping Array: From Substrains to SubspeciesAndrew P Morgan, Chen-Ping Fu, Chia-Yu Kao, et al.
European Urology|June 26, 2025
Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate DataSarah Burdett, David J Fisher, Jayne F Tierney, et al.
Histopathology|July 22, 2014
Immunohistochemical application of a highly sensitive and specific murine monoclonal antibody recognising the extracellular domain of the human hepatocyte growth factor receptor (MET)Aaron M Gruver, Ling Liu, Peter Vaillancourt, et al.
Journal of Bacteriology|September 29, 2011
Genome sequences for five strains of the emerging pathogen Haemophilus haemolyticusI King Jordan, Andrew B Conley, Ivan V Antonov, et al.
Lancet (London, England)|December 4, 2019
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trialAndrew R Clamp, Elizabeth C James, Iain A McNeish, et al.
Journal of the National Cancer Institute|January 20, 2005
Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Scott M Lippman, Phyllis J Goodman, Eric A Klein, et al.
Pageof 168